Clinical Trial: A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06976268) titled 'A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease' on May 09.

Brief Summary: A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease.

Study Start Date: May, 2025

Study Type: INTERVENTIONAL

Condition: Parkinson Disease

Intervention: DRUG: BHV-8000

BHV-8000 10 mg. Participants will take blinded investigational product (IP) once daily

DRUG: BHV-8000

BHV-8000 20 mg. Participants will take blinded investigational product (IP) once daily

DRUG: Placebo

Matching placebo taken once daily

Re...